サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1388148

片側視野欠損市場、シェア、市場規模、動向、産業分析レポート：タイプ別、治療別、エンドユーザー別、地域別、セグメント別予測、2023年～2032年

Hemianopsia Market Share, Size, Trends, Industry Analysis Report, By Type (Homonymous Hemianopsia, Quadrantanopsia, and Bitemporal Hemianopsia); By Treatment; By End User; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
片側視野欠損市場、シェア、市場規模、動向、産業分析レポート：タイプ別、治療別、エンドユーザー別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年10月23日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris market researchの最新調査によると、世界の片側視野欠損市場規模は2032年までに6億7,629万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

片側視野欠損を含む視覚障害に対する医療従事者、患者、一般市民の意識の高まり、早期診断と適切な治療に対する需要の高まり、新しい治療法や診断の有効性を検証するための研究や臨床試験への投資が、市場全体の成長を促進する顕著な要因となっています。

また、先進的な画像診断技術や視野検査法などの診断ツールの急速な開拓により、片側視野欠損の診断の精度と効率が向上していることや、バーチャルリアリティ、コンピュータベースのトレーニング、神経刺激技術などの神経リハビリテーション療法の革新も、市場に有利な成長機会を生み出す要因の一つとなっています。例えば、2023年4月、Sensoria Health社は、Sensoria社が提供するNeurOpTrekと名付けられた新しいウェアラブルシステムの発売を発表しました。

ウェアラブルデバイス、バーチャルリアリティシステム、モバイルアプリケーション、コンピュータベースのトレーニングプログラムなど、さまざまなタイプのデバイスやシステムにわたる技術の統合が急増しており、主に片側視野欠損の患者の日常生活のさまざまな側面を支援するため、また、視野欠損を補い、機能的視力を高め、自立と生活の質をサポートするこれらの技術の能力は、世界市場の最も新しい動向の一つです。

また、近年、片側視野欠損の治療において神経可塑性とリハビリテーションのアプローチが重視されるようになってきており、研究者や臨床医が急増し、啓発キャンペーン、教材、会議の普及と相まって、目標とするトレーニングを通じて皮質の再編成と視野の機能回復を促進する技術を模索しており、世界中で片側視野欠損の認識と管理の向上に貢献しています。

片側視野欠損市場レポートハイライト

腫瘍や脳卒中などさまざまな原因による一般的な視覚障害疾患の有病率の増加により、同名片側視野欠損分野が2022年の世界市場シェアで最大を占める

視力回復治療分野は2022年に最大の市場収益シェアを占めたが、これは主にこれらの治療の重要性を認識する規制機関の増加によるものです。

専門クリニック分野は、先進的な新規治療法の導入が増加していることから、調査期間中にCAGRが大幅に上昇し、最も急成長している地域になると予測されています。

北米地域は2022年に大きなシェアを獲得し、業界市場をリードしました。これは、同地域で医療インフラが整備され、手術件数が増加しているためです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の片側視野欠損市場に関する洞察

  • 片側視野欠損市場- エンドユーザーのスナップショット
  • 片側視野欠損市場力学
    • 促進要因と機会
      • 技術の進歩
      • 脳損傷の発生率の増加
    • 抑制要因と課題
      • 高額な治療費
  • PESTEL分析
  • 片側視野欠損市場のエンドユーザー動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の片側視野欠損市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 同名半盲
  • 四分の一盲
  • 両側半盲

第6章 世界の片側視野欠損市場、治療別

  • 主な調査結果
  • イントロダクション
  • 視力回復療法
  • 視野拡張補助具

第7章 世界の片側視野欠損市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 専門クリニック

第8章 世界の片側視野欠損市場、地域別

  • 主な調査結果
  • イントロダクション
    • 片側視野欠損市場評価、地域別、2019-2032年
  • 片側視野欠損市場-北米
    • 北米：片側視野欠損市場、タイプ別、2019-2032
    • 北米：片側視野欠損市場、エンドユーザー別、2019～2032年
    • 北米：片側視野欠損市場、治療別、2019-2032年
    • 片側視野欠損市場-米国
    • 片側視野欠損市場- カナダ
  • 片側視野欠損市場- 欧州
    • 欧州：片側視野欠損市場、タイプ別、2019～2032年
    • 欧州：片側視野欠損市場、エンドユーザー別、2019～2032年
    • 欧州：片側視野欠損市場、治療別、2019-2032
    • 片側視野欠損市場- 英国
    • 片側視野欠損市場- フランス
    • 片側視野欠損市場- ドイツ
    • 片側視野欠損市場-イタリア
    • 片側視野欠損市場- スペイン
    • 片側視野欠損市場-オランダ
    • 片側視野欠損市場- ロシア
  • 片側視野欠損市場- アジア太平洋
    • アジア太平洋：片側視野欠損市場、タイプ別、2019～2032年
    • アジア太平洋：片側視野欠損市場、エンドユーザー別、2019～2032年
    • アジア太平洋：片側視野欠損市場、治療別、2019～2032年
    • 片側視野欠損市場- 中国
    • 片側視野欠損市場- インド
    • 片側視野欠損市場- マレーシア
    • 片側視野欠損市場- 日本
    • 片側視野欠損市場- インドネシア
    • 片側視野欠損市場- 韓国
  • 片側視野欠損市場-中東およびアフリカ
    • 中東およびアフリカ：片側視野欠損市場、タイプ別、2019～2032年
    • 中東およびアフリカ：片側視野欠損市場、エンドユーザー別、2019～2032年
    • 中東およびアフリカ：片側視野欠損市場、治療別、2019～2032年
    • 片側視野欠損市場- サウジアラビア
    • 片側視野欠損市場- アラブ首長国連邦
    • 片側視野欠損市場- イスラエル
    • 片側視野欠損市場- 南アフリカ
  • 片側視野欠損市場-ラテンアメリカ
    • ラテンアメリカ：片側視野欠損市場、タイプ別、2019-2032
    • ラテンアメリカ：片側視野欠損市場、エンドユーザー別、2019～2032年
    • ラテンアメリカ：片側視野欠損市場、治療別、2019～2032年
    • 片側視野欠損市場- メキシコ
    • 片側視野欠損市場- ブラジル
    • 片側視野欠損市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • AbbVie Inc.
  • Aerie Pharmaceuticals Inc.
  • AkzoNobel N.V.
  • Carl Zeiss AG
  • Chadwick Optical
  • EyeTech Digital Systems
  • F. Hoffmann-La Roche Ltd.
  • Genetech Inc.
  • Healio
  • LumiThera Inc.
  • NeuroVision Imaging LLC
  • Novartis AG
  • NovaVision
  • RetroSense Therapeutics LLC
  • Samsung Medical Center
  • VisionCare Inc.
  • Vycor Medical Inc.
図表

List of Tables

  • Table 1 Global Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 3 Global Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 4 Hemianopsia Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 6 North America: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 7 North America: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 10 U.S.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 12 Canada: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 13 Canada: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 15 Europe: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 16 Europe: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 18 UK: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 19 UK: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 21 France: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 22 France: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 24 Germany: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 25 Germany: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 27 Italy: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 28 Italy: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 30 Spain: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 31 Spain: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 34 Netherlands: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 36 Russia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 37 Russia: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 42 China: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 43 China: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 45 India: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 46 India: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 49 Malaysia: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 51 Japan: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 52 Japan: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 55 Indonesia: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 58 South Korea: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 66 UAE: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 67 UAE: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 69 Israel: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 70 Israel: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 73 South Africa: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 76 Latin America: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 79 Mexico: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 82 Brazil: Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • Table 85 Argentina: Hemianopsia Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Hemianopsia Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Treatment
  • Figure 7. Global Hemianopsia Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Hemianopsia Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Hemianopsia Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Hemianopsia Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Hemianopsia Market
目次
Product Code: PM3843

The global hemianopsia market size is expected to reach USD 676.29 million by 2032, according to a new study by Polaris market research. The report "Hemianopsia Market Share, Size, Trends, Industry Analysis Report, By Type (Homonymous Hemianopsia, Quadrantanopsia, and Bitemporal Hemianopsia); By Treatment; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing awareness among healthcare professionals, patients, and the general public about visual impairments, including hemianopsia, leading demand for early diagnosis and appropriate treatment, along with the investment in research and clinical trials helping validate the efficacy of new treatments and diagnosis, are prominent factors propelling the overall market growth.

The rapid development of diagnostic tools, such as advanced imaging techniques and visual field-testing methods, that results in improving accuracy and efficiency in diagnosing hemianopsia and innovations in neuro-rehabilitation therapies, which include virtual reality, computer-based training, and neuro-stimulation techniques, has also been among the factors creating lucrative growth opportunities for the market. For instance, in April 2023, Sensoria Health announced the launch of its new wearable system named NeurOpTrek, powered by Sensoria, which is designed to improve vision and help to reduce the risk of falls, a serious health concern mainly for older adults.

The surging technology integration across various types of devices and systems, including wearable devices, virtual reality systems, mobile applications, and computer-based training programs, mainly to assist individuals with hemianopsia in various aspects of their daily lives and the ability of these technologies to compensate for visual field deficits, enhance functional vision, and support independence and quality of life, are among the most emerging trends in the global market.

Additionally, there has been a growing emphasis on neuroplasticity and rehabilitation approaches in the treatment of hemianopsia in recent years, and a surging number of researchers and clinicians are exploring techniques that promote cortical reorganization and functional recovery of the visual field through targeted training coupled with the proliferation for awareness campaigns, educational materials, and conferences, contributing to improved recognition and management of hemianopsia all over the world.

Hemianopsia Market Report Highlights

Homonymous hemianopsia segment accounted for largest global market share in 2022, owing to increasing prevalence of diseases as common visual impairment due to different causes including tumors and stroke

Vision restoration therapy segment held the maximum market revenue share in 2022, which is mainly driven by rising number of regulatory agencies recognizing the importance of these therapies

Specialty clinics segment is projected to emerge as fastest growing region with a significant CAGR over the study period, due to rising incorporation of advanced novel therapies

North America region led the industry market with substantial share in 2022, on account of robust presence of developed healthcare infrastructure and number of surgeries being performed across the region

The global key market players include: F. Hoffman-La Roche, Novartis AG, Aerie Pharmaceuticals, AkzoNobel N.V., AbbVie Inc., EyeTech Digital Systems, and NeuroVision Imaging LLC

Polaris market research has segmented the Hemianopsia market report based on type, treatment, end user, and region:

Hemianopsia, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Homonymous Hemianopsia
  • Quadrantanopsia
  • Bitemporal Hemianopsia

Hemianopsia, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Vision Restoration Therapy
  • Visual Field Expander Aid

Hemianopsia, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Specialty Clinics

Hemianopsia, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Hemianopsia Market Insights

  • 4.1. Hemianopsia Market - End User Snapshot
  • 4.2. Hemianopsia Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Technological Advancement
      • 4.2.1.2. Increasing Incidence of Brain Injuries
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Hemianopsia Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Hemianopsia Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Hemianopsia Market, by Type, 2019-2032 (USD Million)
  • 5.3. Homonymous Hemianopsia
    • 5.3.1. Global Hemianopsia Market, by Homonymous Hemianopsia, by Region, 2019-2032 (USD Million)
  • 5.4. Quadrantanopsia
    • 5.4.1. Global Hemianopsia Market, by Quadrantanopsia, by Region, 2019-2032 (USD Million)
  • 5.5. Bitemporal Hemianopsia
    • 5.5.1. Global Hemianopsia Market, by Bitemporal Hemianopsia, by Region, 2019-2032 (USD Million)

6. Global Hemianopsia Market, by Treatment

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • 6.3. Vision Restoration Therapy
    • 6.3.1. Global Hemianopsia Market, by Vision Restoration Therapy, by Region, 2019-2032 (USD Million)
  • 6.4. Visual Field Expander Aid
    • 6.4.1. Global Hemianopsia Market, by Visual Field Expander Aid, by Region, 2019-2032 (USD Million)

7. Global Hemianopsia Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Hemianopsia Market, by End User, 2019-2032 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Global Hemianopsia Market, by Hospitals, By Region, 2019-2032 (USD Million)
  • 7.4. Specialty Clinics
    • 7.4.1. Global Hemianopsia Market, by Specialty Clinics, By Region, 2019-2032 (USD Million)

8. Global Hemianopsia Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Hemianopsia Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Hemianopsia Market - North America
    • 8.3.1. North America: Hemianopsia Market, by Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Hemianopsia Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.4. Hemianopsia Market - U.S.
      • 8.3.4.1. U.S.: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.5. Hemianopsia Market - Canada
      • 8.3.5.1. Canada: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • 8.4. Hemianopsia Market - Europe
    • 8.4.1. Europe: Hemianopsia Market, by Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.4. Hemianopsia Market - UK
      • 8.4.4.1. UK: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.5. Hemianopsia Market - France
      • 8.4.5.1. France: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.6. Hemianopsia Market - Germany
      • 8.4.6.1. Germany: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.7. Hemianopsia Market - Italy
      • 8.4.7.1. Italy: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.8. Hemianopsia Market - Spain
      • 8.4.8.1. Spain: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.9. Hemianopsia Market - Netherlands
      • 8.4.9.1. Netherlands: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.10. Hemianopsia Market - Russia
      • 8.4.10.1. Russia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • 8.5. Hemianopsia Market - Asia Pacific
    • 8.5.1. Asia Pacific: Hemianopsia Market, by Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.4. Hemianopsia Market - China
      • 8.5.4.1. China: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.5. Hemianopsia Market - India
      • 8.5.5.1. India: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.6. Hemianopsia Market - Malaysia
      • 8.5.6.1. Malaysia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.7. Hemianopsia Market - Japan
      • 8.5.7.1. Japan: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.8. Hemianopsia Market - Indonesia
      • 8.5.8.1. Indonesia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.9. Hemianopsia Market - South Korea
      • 8.5.9.1. South Korea: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • 8.6. Hemianopsia Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Hemianopsia Market, by Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.4. Hemianopsia Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.5. Hemianopsia Market - UAE
      • 8.6.5.1. UAE: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.6. Hemianopsia Market - Israel
      • 8.6.6.1. Israel: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.7. Hemianopsia Market - South Africa
      • 8.6.7.1. South Africa: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
  • 8.7. Hemianopsia Market - Latin America
    • 8.7.1. Latin America: Hemianopsia Market, by Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.4. Hemianopsia Market - Mexico
      • 8.7.4.1. Mexico: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.5. Hemianopsia Market - Brazil
      • 8.7.5.1. Brazil: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.6. Hemianopsia Market - Argentina
      • 8.7.6.1. Argentina: Hemianopsia Market, by Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Hemianopsia Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Hemianopsia Market, by Treatment, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Aerie Pharmaceuticals Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3.AkzoNobel N.V.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Carl Zeiss AG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Chadwick Optical
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. EyeTech Digital Systems
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. F. Hoffmann-La Roche Ltd.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Genetech Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Healio
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. LumiThera Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. NeuroVision Imaging LLC
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Novartis AG
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. NovaVision
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. RetroSense Therapeutics LLC
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Samsung Medical Center
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. VisionCare Inc.
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. Vycor Medical Inc.
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development